PROSEEK: a Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This study is designed to assess the ability of K0706 to slow the progression of PD. Preclinical animal model data have already demonstrated that K0706 has neuroprotective activity, but further development will require human clinical experience. This study will also allow determination of safety and tolerability of K0706 over many months in subjects with PD.
Epistemonikos ID: f73f6c726e4484781a3d16199d78f11255e47fee
First added on: May 21, 2024